Journal Information
Vol. 93. Issue 3.
Pages 475-476 (01 May 2018)
Share
Share
Download PDF
More article options
Vol. 93. Issue 3.
Pages 475-476 (01 May 2018)
Open Access
Chromoblastomycosis due to Cladosporium langeronii. Molecular diagnosis of an agent previously diagnosed as Fonsecaea pedrosoi*
Visits
2928
Edoardo Torres-Guerrero1, Roberto Arenas1, Rigoberto Hernández Castro2
1 Mycology Service – Hospital “Dr. Manuel Gea González”, Ciudad del Mexico, Mexico.
2 Research Department, Ecology of Pathogen Agents Sector - Hospital “Dr. Manuel Gea González”, Ciudad del Mexico, Mexico.
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Full Text

Dear Editor,

Chromoblastomycosis is a chronic, progressive, subcutaneous mycosis caused by dematiaceous (black) fungi clinically characterized by warty nodular lesions, generally on lower limbs but any region can be involved. The etiological agents mainly belong to three genera: Fonsecaea, Phialophora and Cladophialophora (Cladosporium). All of these pathogens are characterized by parasitic structures known as fumagoid cells or Medlar bodies. Most of affected individuals are rural workers who have a history of local trauma with decaying plant debri and frequently wear inadequate footwear, such as sandals. In 2010, we published a clinical case regarding a patient with squamous cell carcinoma secondary to longstanding lesions of chromoblastomycosis, who died due to multiorgan failure with hydroelectrolytic imbalance.1 Based on phenotypic fungal characteristics, the culture had been previously identified as Fonseaea pedrosoi. The culture was stored and now, ten years after the case release, we carried out polymerase chain reaction (PCR) amplification and sequencing of internal transcribed spacer (ITS) and ribosomal DNA (rDNA; Figures 1 and 2).2 The 550 bp PCR product was purified, sequenced in both directions and submitted to the BLAST database at NCBI. The sequence showed a 100% homology with Cladosporium langeronii DTO-124-D5, R1, CBS189.54, among others (Figure 3).

Figure 1.

Chromoblastomycosis. Medlar bodies (Hematoxylin & eosin, X40)

(0.81MB).
Figure 2.

Chromoblastomycosis. Medlar bodies (PAS, X10)

(0.34MB).
Figure 3.

PCR amplification of the rDNA-ITS region: 1) Negative control; 2) Molecular weight marker 100bp ladder; and 3) C. langeronii isolate

(0.17MB).

In 2006, Zalar et al. described C. langeronii, along with seven new species sampled from a variety of substrates, as species related to the ubiquitous Cladosporium sphaerospermum. This description and phylogenetic analysis was based on the amplification and sequence of the rDNA-ITS region.3Cladosporium species are particularly distinguished by their strikingly slow-growing colonies in potato dextrose agar, malt extract agar and oat agar at 25°C in the dark with a maximum salt concentration of 17%. Cladosporium develop dark-brown smooth oblong conidia with light ornamentations (minutely verruculose spores) and scarce secondary ramoconidia.4Cladosporium are ubiquitous without any apparent predilection for a specific environment. Its habitat comprises polar ice, decomposing plant matter, window frames, nasal mucus, and more recently, water from the Caspian Sea.5 Clinical cases are suspected to be accidental as a consequence of traumatism involving contaminated materials.

The classical identification based on macroscopic and microscopic characteristics provides a weak diagnosis. Currently, molecular techniques based on the rDNA-ITS region of Cladosporium allow more precise species identification. Thus, we communicate the molecular confirmation C. langeronii as the causative agent of the 2007 clinical case. So far, only three sequences of C. langeronii rDNA-ITS have been reported associated with human cases. The first sequence, CBS189.54 NT (access number DQ780379), is associated with mycosis in Brazil, while the other two sequences (access numbers AF4555254 and AY3453524) are related to nasal mucosa.3 We believe communicating the molecular confirmation of a human disease caused by this extremely rare agent is important.

Financial support: None.

Conflict of interests: None.

References
[1.]
M. Tanaka, S. Shimizu.
Hidradenoma papilliferum occurring on the chest of a man.
J Am Acad Dermatol, 48 (2003), pp. S20-S21
[2.]
A. Virgili, A. Marzola, M. Corazza.
Vulvar Hidradenoma Papilliferum.
A review of 10.5-year’s experience. J Reprod Med, 45 (2000), pp. 616-618
[3.]
Y. Handa, N. Yamanaka, H. Inagaki, Y. Tomita.
Large Ulcerated Perianal Hidradenoma Papilliferum in a Young Female.
Dermatol Surg, 29 (2003), pp. 790-792
[4.]
Y.J. Kim, J.W. Lee, S.J. Choi, S.J. Kim, Y.J. Kim, Y.S. Jeon.
Ectopic Hidradenoma Papilliferum of the Breast: Ultrasound Finding.
J Breast Cancer, 14 (2011), pp. 153-155
[5.]
G. Theodosiou, V. Zafeiriadou, M. Papageorgiou, I. Mandekou-Lefaki.
An unusual lesion in the right place.
Dermatol Pract Concept, 6 (2016), pp. 7-9

Work conducted at the Mycology Service and Ecology of Pathogen Agents Sector, Hospital “Dr. Manuel Gea González”, Ciudad del Mexico, Mexico.

Copyright © 2018. Anais Brasileiros de Dermatologia
Idiomas
Anais Brasileiros de Dermatologia
Article options
Tools
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.